Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Ordinary shares, nominal value 0.0025 per share
-
Shares outstanding
-
328,915,843
-
Number of holders
-
3
-
Total 13F shares, excl. options
-
630,301
-
Shares change
-
+103,728
-
Total reported value, excl. options
-
$4,172,000
-
Value change
-
+$689,922
-
Number of buys
-
2
-
Price
-
$6.55
Significant Holders of Renalytix plc - Ordinary shares, nominal value 0.0025 per share as of Q2 2020
3 filings reported holding G7489R108 - Renalytix plc - Ordinary shares, nominal value 0.0025 per share as of Q2 2020.
Renalytix plc - Ordinary shares, nominal value 0.0025 per share has 3 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 630,301 shares
of 328,915,843 outstanding shares and own 0.19% of the company stock.
Largest 3 shareholders include GILDER GAGNON HOWE & CO LLC (246,582 shares), GOFEN & GLOSSBERG LLC /IL/ (222,700 shares), and TIAA, FSB (161,019 shares).
This table shows the top 3 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.